The historical rank and industry rank for BATM Advanced Communications's EV-to-EBIT or its related term are showing as below:
LSE:BVC'
s EV-to-EBIT Range Over the Past 10 Years
Min: -407.23 Med: 26.18 Max: 141.84
Current: 24.09
During the past 13 years, the highest EV-to-EBIT of BATM Advanced Communications was 141.84. The lowest was -407.23. And the median was 26.18.
LSE:BVC's EV-to-EBIT is ranked worse than 60.4% of 452
companies
in the Medical Devices & Instruments industry
Industry Median: 19.63
vs LSE:BVC: 24.09
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BATM Advanced Communications's EV-to-EBIT
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's EV-to-EBIT falls into.
BATM Advanced Communications's current Enterprise Value is £54.01 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BATM Advanced Communications's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £2.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
BATM Advanced Communications's Enterprise Value for the quarter that ended in Dec. 2023 was £62.58 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BATM Advanced Communications's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £2.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of BATM Advanced Communications's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
BATM Advanced Communications (LSE:BVC) Business Description
BATM Advanced Communications Ltd is an Israel-based technology company. The company organizes its business operations into two divisions: Networking & Cyber Division and Biomedical Division. Networking and Cyber Division mostly includes the research and development, production, and marketing of data communication products in the field of local and wide area networks and premises management systems. Bio-Medical Division is engaged in the research and development, production, marketing, and distribution of medical products, primarily laboratory diagnostic equipment and sterilization equipment. The majority of its revenue is derived from Biomedical Division. Its geographical segments are the United States of America, Israel, and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:BVC has been successfully added to your 